Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-10-09

Clinical Trial Update: Twitter-enabled Mobile Messaging for Smoking Relapse Prevention [NA]

View source ↗

Summary

A completed clinical trial evaluated Twitter-enabled mobile messaging to prevent smoking relapse; results were posted on 2024-10-09.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of California, Irvine | Conditions: Smoking | NA | Status: COMPLETED | Results posted: 2024-10-09